ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. Western European Journal of Medicine and Medical Science, [S. l.], v. 2, n. 6, p. 11–20, 2024. Disponível em: https://westerneuropeanstudies.com/index.php/3/article/view/1131. Acesso em: 25 mar. 2026.